Allero Therapeutics is a biopharmaceutical company.
Allero Therapeutics has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in October 2021.
Allero Therapeutics's investors include European Innovation Council, EISMEA, Swanbridge Capital.
Allero Therapeutics is headquartered in Rotterdam, The Netherlands.
Allero Therapeutics is a biopharmaceutical company.
Allero Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allero Therapeutics — Funding & Investors." VCBacked, October 21, 2021, https://www.vcbacked.co/company/allero-therapeutics. Accessed November 14, 2026.
VCBacked. (2021). Allero Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/allero-therapeutics
{{cite web |title=Allero Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allero-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Allero Therapeutics? Request a listing update